annual ROE:
435.49%+299.27%(+219.70%)Summary
- As of today (July 1, 2025), CYTK annual return on equity is 435.49%, with the most recent change of +299.27% (+219.70%) on December 31, 2024.
- During the last 3 years, CYTK annual ROE has risen by +556.03% (+461.28%).
- CYTK annual ROE is now at all-time high.
Performance
CYTK ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly ROE:
801.26%+261.52%(+48.45%)Summary
- As of today (July 1, 2025), CYTK quarterly return on equity is 801.26%, with the most recent change of +261.52% (+48.45%) on March 1, 2025.
- Over the past year, CYTK quarterly ROE has increased by +664.72% (+486.83%).
- CYTK quarterly ROE is now -46.78% below its all-time high of 1505.62%, reached on December 31, 2019.
Performance
CYTK quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CYTK ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +219.7% | +486.8% |
| 3 y3 years | +461.3% | +531.3% |
| 5 y5 years | +126.8% | +23.8% |
CYTK ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +176.1% | at high | +243.2% |
| 5 y | 5-year | at high | +126.8% | at high | +126.1% |
| alltime | all time | at high | +126.8% | -46.8% | +126.1% |
CYTK ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | 801.26%(+48.5%) |
| Dec 2024 | 435.49%(+219.7%) | 539.74%(+61.0%) |
| Sep 2024 | - | 335.19%(+71.0%) |
| Jun 2024 | - | 196.01%(+43.6%) |
| Mar 2024 | - | 136.54%(-10.0%) |
| Dec 2023 | 136.22%(-123.8%) | 151.74%(-20.1%) |
| Sep 2023 | - | 190.01%(-39.6%) |
| Jun 2023 | - | 314.64%(-55.9%) |
| Mar 2023 | - | 713.59%(-227.6%) |
| Dec 2022 | -572.15%(+374.7%) | -559.39%(+179.4%) |
| Sep 2022 | - | -200.22%(+36.7%) |
| Jun 2022 | - | -146.48%(-21.1%) |
| Mar 2022 | - | -185.77%(+19.2%) |
| Dec 2021 | -120.54%(-51.5%) | -155.89%(-18.7%) |
| Sep 2021 | - | -191.73%(-33.7%) |
| Jun 2021 | - | -289.26%(-11.3%) |
| Mar 2021 | - | -325.99%(-34.3%) |
| Dec 2020 | -248.50%(-84.7%) | -496.22%(-83.8%) |
| Sep 2020 | - | -3065.13%(-943.8%) |
| Jun 2020 | - | 363.26%(-43.9%) |
| Mar 2020 | - | 647.22%(-57.0%) |
| Dec 2019 | -1622.88%(+936.5%) | 1505.62%(-245.1%) |
| Sep 2019 | - | -1037.98%(+186.3%) |
| Jun 2019 | - | -362.56%(+76.3%) |
| Mar 2019 | - | -205.69%(+40.3%) |
| Dec 2018 | -156.57%(+25.1%) | -146.56%(+17.9%) |
| Sep 2018 | - | -124.36%(+15.5%) |
| Jun 2018 | - | -107.68%(+2.1%) |
| Mar 2018 | - | -105.45%(+2.6%) |
| Dec 2017 | -125.16%(-719.9%) | -102.79%(+52.6%) |
| Sep 2017 | - | -67.35%(+363.8%) |
| Jun 2017 | - | -14.52%(-462.1%) |
| Mar 2017 | - | 4.01%(-82.8%) |
| Dec 2016 | 20.19%(-143.2%) | 23.31%(>+9900.0%) |
| Sep 2016 | - | 0.10%(-100.2%) |
| Jun 2016 | - | -66.39%(+14.0%) |
| Mar 2016 | - | -58.22%(+20.1%) |
| Dec 2015 | -46.69%(+133.6%) | -48.46%(+91.6%) |
| Sep 2015 | - | -25.29%(+20.4%) |
| Jun 2015 | - | -21.01%(+18.0%) |
| Mar 2015 | - | -17.81%(-6.4%) |
| Dec 2014 | -19.99% | -19.02%(-23.6%) |
| Sep 2014 | - | -24.88%(-33.2%) |
| Jun 2014 | - | -37.25%(-27.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | -51.31%(-16.4%) |
| Dec 2013 | -54.15%(-20.7%) | -61.37%(-28.6%) |
| Sep 2013 | - | -85.93%(+22.7%) |
| Jun 2013 | - | -70.01%(+10.9%) |
| Mar 2013 | - | -63.12%(+3.5%) |
| Dec 2012 | -68.27%(-15.3%) | -61.01%(-5.0%) |
| Sep 2012 | - | -64.24%(-5.8%) |
| Jun 2012 | - | -68.17%(-19.2%) |
| Mar 2012 | - | -84.34%(+6.3%) |
| Dec 2011 | -80.64%(+40.7%) | -79.33%(+9.9%) |
| Sep 2011 | - | -72.20%(+5.5%) |
| Jun 2011 | - | -68.45%(+8.6%) |
| Mar 2011 | - | -63.04%(+9.7%) |
| Dec 2010 | -57.33%(-276.6%) | -57.45%(+7.7%) |
| Sep 2010 | - | -53.32%(+18.9%) |
| Jun 2010 | - | -44.83%(-284.3%) |
| Mar 2010 | - | 24.32%(-14.8%) |
| Dec 2009 | 32.47%(-143.1%) | 28.55%(-16.0%) |
| Sep 2009 | - | 33.99%(+29.5%) |
| Jun 2009 | - | 26.25%(-131.0%) |
| Mar 2009 | - | -84.80%(+10.2%) |
| Dec 2008 | -75.33%(+58.9%) | -76.97%(+11.6%) |
| Sep 2008 | - | -68.99%(+23.0%) |
| Jun 2008 | - | -56.08%(+16.2%) |
| Mar 2008 | - | -48.27%(+8.4%) |
| Dec 2007 | -47.42%(-25.3%) | -44.53%(-7.7%) |
| Sep 2007 | - | -48.24%(-9.4%) |
| Jun 2007 | - | -53.27%(-4.4%) |
| Mar 2007 | - | -55.71%(-10.8%) |
| Dec 2006 | -63.51%(+36.1%) | -62.45%(+2.6%) |
| Sep 2006 | - | -60.87%(+10.8%) |
| Jun 2006 | - | -54.96%(+8.5%) |
| Mar 2006 | - | -50.64%(+6.6%) |
| Dec 2005 | -46.66%(-90.3%) | -47.50%(+8.2%) |
| Sep 2005 | - | -43.91%(+9.9%) |
| Jun 2005 | - | -39.96%(-32.3%) |
| Mar 2005 | - | -59.01%(-47.8%) |
| Dec 2004 | -479.20%(-1449.1%) | -113.01%(-52.0%) |
| Sep 2004 | - | -235.30%(-252.7%) |
| Jun 2004 | - | 154.09%(+386.2%) |
| Mar 2004 | - | 31.69%(-6.5%) |
| Dec 2003 | 35.52%(-6.7%) | 33.91% |
| Dec 2002 | 38.09%(-10.4%) | - |
| Dec 2001 | 42.50%(-29.1%) | - |
| Dec 2000 | 59.95% | - |
FAQ
- What is Cytokinetics Incorporated annual return on equity?
- What is the all time high annual ROE for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated annual ROE year-on-year change?
- What is Cytokinetics Incorporated quarterly return on equity?
- What is the all time high quarterly ROE for Cytokinetics Incorporated?
- What is Cytokinetics Incorporated quarterly ROE year-on-year change?
What is Cytokinetics Incorporated annual return on equity?
The current annual ROE of CYTK is 435.49%
What is the all time high annual ROE for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high annual return on equity is 435.49%
What is Cytokinetics Incorporated annual ROE year-on-year change?
Over the past year, CYTK annual return on equity has changed by +299.27% (+219.70%)
What is Cytokinetics Incorporated quarterly return on equity?
The current quarterly ROE of CYTK is 801.26%
What is the all time high quarterly ROE for Cytokinetics Incorporated?
Cytokinetics Incorporated all-time high quarterly return on equity is 1505.62%
What is Cytokinetics Incorporated quarterly ROE year-on-year change?
Over the past year, CYTK quarterly return on equity has changed by +664.72% (+486.83%)